Brief Article on New iwCLL Guidelines - CLL Support

CLL Support

23,337 members40,043 posts

Brief Article on New iwCLL Guidelines

2 Replies

You need to be a member of this community to see this post.

Read more about...
2 Replies

You need to be a member of this community to see hidden responses.

Not what you're looking for?

You may also like...

Potential Early Drivers of Disease in Treatment-Naive CLL Identified

This study reinforces others regarding mutations that predict a short time to first treatment....
Jm954 profile image
Administrator

Determining if you'll never need treatment. It is feasible and safe to stop specialized follow-up of asymptomatic lower risk CLL?

Regular readers will have often heard that around 30% of those diagnosed with CLL never need...
AussieNeil profile image
Partner

Ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial treatment for younger patients with CLL

This is an abstract from the Lancet article. There's a fair bit of detail missing regarding the...
Jm954 profile image
Administrator

Use of MRD Status Following Obinutuzumab/Ibrutinib to Guide Subsequent Intensification of Therapy in CLL

August 6, 2019 In this 2-part, single-arm, open-label, multicenter trial (Clinical Trials.gov...
Jm954 profile image
Administrator

SF3B1 Mutations

We've had a couple of members mention that they are positive for SF3B1 Mutations so I thought it...
Jm954 profile image
Administrator